本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Sarepta Therapeutics

62.40
+1.552.55%
盤前62.870.4700+0.75%09:09 EDT
成交量:157.71萬
成交額:9,740.07萬
市值:61.31億
市盈率:26.69
高:62.51
開:59.98
低:59.62
收:60.85
資料載入中...
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/09

重要事件披露

Form 8-K - Current report
2023/11/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report